Latest Asx Listing News

Vinyl Group Ltd has reported a landmark quarter with record cash receipts up 80% quarter-on-quarter and its first operating cash flow positive result, signalling a turning point for the music and culture company.

Bellevue Gold Limited reported a robust cash flow and significant debt reduction in its December 2025 quarter, ending with a strong cash position of A$165.1 million. The company made early principal repayments on its project loan facility, lowering outstanding debt to A$100 million.

Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.

Djerriwarrh Investments Limited has announced a refreshed on-market buy-back program, aiming to repurchase up to 24 million ordinary shares over the next year as part of its capital management strategy.

The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.

Alice Queen Limited has addressed a recent doubling in its share price, attributing the surge to rising gold prices and ongoing project developments rather than undisclosed information.

Hiremii Group has raised $1.764 million through a strategic placement to fuel growth of its AI-driven recruitment platform and appointed Vaughan Webber as its new Chair.

4DMedical Limited has raised AU$150 million to accelerate the commercial rollout of its FDA-cleared CT, VQ lung imaging technology in the US, leveraging a strategic partnership with Philips. This funding aims to expand adoption across major medical centres and government healthcare programs.

Thor Energy has received an initial A$2.25 million payment from the sale of its Molyhil project interest, with further payments set to boost its cash reserves and fund expansion in hydrogen and copper assets.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

Syrah Resources and Tesla have agreed to extend the cure date for an alleged default under their offtake agreement to March 2026, buying time to resolve ongoing qualification issues at Syrah’s Vidalia facility.

La Trobe Financial Capital Markets Trust 2022-1 has completed the redemption of its Class A1L and A2 Notes, leading to their suspension and removal from the ASX Official List.